Cargando…

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity

Combination antiretroviral therapy (ART) is highly effective in controlling human immunodeficiency virus (HIV)-1 but requires lifelong medication due to the existence of a latent viral reservoir(1,2). Potent broadly neutralizing antibodies (bNAbs) represent a potential alternative or adjuvant to ART...

Descripción completa

Detalles Bibliográficos
Autores principales: Niessl, Julia, Baxter, Amy E., Mendoza, Pilar, Jankovic, Mila, Cohen, Yehuda Z., Butler, Allison L., Lu, Ching-Lan, Dubé, Mathieu, Shimeliovich, Irina, Gruell, Henning, Klein, Florian, Caskey, Marina, Nussenzweig, Michel C., Kaufmann, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018622/
https://www.ncbi.nlm.nih.gov/pubmed/32015556
http://dx.doi.org/10.1038/s41591-019-0747-1